Szela Mary T (CIK 1410289) reported 19 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-06). Recent activity: Buy ABSI (12,900 shares), Buy TLSI (3,990 shares), Buy TLSI (3,530 shares), Buy TLSI (2,848 shares), Buy TLSI (2,100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Absci Corp (ABSI) | Director | Buy | 12,900 | $148,866 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 3,990 | $15,441 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 3,530 | $15,038 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 2,848 | $12,047 |
| 2026-07-01 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 2,100 | $9,198 |
| 2026-06-08 | Absci Corp (ABSI) | Director | Buy | 10,100 | $0 |
| 2026-05-18 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 39,682 | $102,776 |
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Sell | 4,358 | $17,999 |
| 2026-03-20 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Sell | 15,944 | $61,384 |
| 2026-02-23 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 30,487 | $124,997 |
| 2025-11-25 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 125,000 | $0 |
| 2025-11-25 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 125,000 | $0 |
| 2025-11-25 | TriSalus Life Sciences, Inc. (TLSI) | CEO and President | Buy | 300,000 | $0 |
| 2025-02-19 | TriSalus Life Sciences, Inc. (TLSI) | CEO AND PRESIDENT | Buy | 21,089 | $0 |
| 2025-01-31 | TriSalus Life Sciences, Inc. (TLSI) | CEO AND PRESIDENT | Buy | 5,030 | $25,301 |
| 2025-01-31 | TriSalus Life Sciences, Inc. (TLSI) | CEO AND PRESIDENT | Buy | 5,010 | $26,453 |
| 2025-01-29 | TriSalus Life Sciences, Inc. (TLSI) | CEO AND PRESIDENT | Buy | 40,000 | $0 |
| 2025-01-29 | TriSalus Life Sciences, Inc. (TLSI) | CEO AND PRESIDENT | Buy | 4,826 | $26,157 |
| 2025-01-29 | TriSalus Life Sciences, Inc. (TLSI) | CEO AND PRESIDENT | Buy | 4,716 | $24,146 |
Source: SEC Form 4 filings · as of 2026-07-06